AstraZeneca (AZN1N) Q2 2026 Earnings Report
MX:AZN1N Q2 2026 EPS Results
- Actual EPS
- MXN 49.42
- Consensus EPS
- MXN 46.53
- Beat/Miss
- Beat by +MXN 2.89
- One Year Ago EPS
- MXN 40.78
MX:AZN1N Q2 2026 Revenue Results
- Actual Revenue
- MXN 288.20B
- Expected Revenue
- MXN 290.07B
- Beat/Miss
- Missed by -MXN 1.87B
- YoY Revenue Growth
- +5.84%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/27/2026
- Time
- Before Open
- Conference Call
- Monday, July 27, 2026
MX:AZN1N Upcoming Earnings
AstraZeneca's next earnings date is estimated for February 11, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:AZN1N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 11, 2027 | 2026 (Q4) | 44.09- | 39.84 | ― | ― |
| Oct 30, 2026 | 2026 (Q3) | 48.6052.43 | 44.73 | 17.23% (+7.70) | |
| Jul 27, 2026 | 2026 (Q2) | 46.5349.42 | 40.78 | 21.20% (+8.64) | |
| Apr 29, 2026 | 2026 (Q1) | 47.3448.48 | 46.79 | 3.61% (+1.69) | |
| Feb 10, 2026 | 2025 (Q4) | 39.2839.84 | 39.28 | 1.44% (+0.56) | |
| Nov 06, 2025 | 2025 (Q3) | 43.0944.73 | 39.09 | 14.42% (+5.64) | |
| Jul 29, 2025 | 2025 (Q2) | 40.5940.78 | 37.21 | 9.60% (+3.57) | |
| Apr 29, 2025 | 2025 (Q1) | 42.3446.79 | 38.71 | 20.87% (+8.08) | |
| Feb 06, 2025 | 2024 (Q4) | 38.9039.28 | 27.25 | 44.14% (+12.03) | |
| Nov 12, 2024 | 2024 (Q3) | 38.3939.09 | 32.51 | 20.23% (+6.58) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
